Cite
HARVARD Citation
Liang, C. et al. (2015). The treatment patterns, efficacy, and safety of nab®-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis. BMC cancer. 15 (1), pp. 1-11. [Online].